Ted White | executive |
Joe Bonaccorso | executive |
P. Terence Kohler | executive |
Stacy Ku | analyst |
Anish Nikhanj | analyst |
Oren Livnat | analyst |
Gary Goldenberg | executive |
Brian Kemp Dolliver | analyst |
Good morning, ladies and gentlemen, and welcome to the Verrica Pharmaceuticals Fourth Quarter and Year-End 2023 Corporate Update and Earnings Conference Call.
As a reminder, this conference is being recorded. I will now turn the call over to our host, Kevin Gardner of LifeSci Advisors.
You may begin your conference.
Thank you, operator.